Searchable abstracts of presentations at key conferences in endocrinology

ea0056ep116 | Pituitary and Neuroendocrinology | ECE2018

Clinical characteristics and management of 4 patients with chordomas of the skull base attending Beaumont Hospital

Maria Tudor Roxana , Forde Hannah , Agha Amar , Faul Clare , Javadpour Mohsen

Introduction: Chordomas are rare slowly growing locally aggressive neoplasms of the bone arising from embryonic remnants of notochord. These tumours typically occur in the axial skeleton and have a proclivity for the spheno-occipital region of the skull base. Parasellar/clivus chordomas account for one third of all chordomas.Methods: We conducted a retrospective chart review of 4 patients with chordomas of the clivus treated in Beaumont Hospital between ...

ea0099p103 | Pituitary and Neuroendocrinology | ECE2024

Prevalence of hypopituitarism in adults treated with intensity-modulated radiotherapy for primary, non-pituitary, brain tumours

Mc Donald Darran , McDermott Niamh , Tomkins Maria , O'Connell Liam , Faul Clare , Fitzpatrick David , Thompson Chris , O'Reilly Michael , Sherlock Mark

Background: Improved survival rates from brain tumours have resulted in patients living longer with the effects of radiotherapy. Advances in conventional fractionated radiotherapy, such as intensity-modulated radiotherapy (IMRT), enable radiation to be delivered more precisely while partially sparing surrounding structures including the hypothalamic-pituitary axis. Despite these advances, the precise risk of hypopituitarism associated with IMRT in survivors of adult-onset non-...

ea0037ep885 | Thyroid cancer | ECE2015

The utility of basal serum thyroglobulin measurement, using a highly sensitive immunoassay, in the follow up of patients treated for differentiated thyroid cancer

Glynn Nigel , Hannon Anne Marie , Schneekloth Lauren , De Buitleir Ciara , Morrin Martina , Keeling Frank , Faul Clare , Leader Mary , Hill Arnold D K , Tormey William , Smith Diarmuid , Thompson Chris J , Agha Amar

Introduction: TSH-stimulated serum thyroglobulin (Tg) is used as a sensitive marker for the detection of early recurrence or residual disease following treatment for differentiated thyroid cancer (DTC). However, stimulated Tg, using TSH or thyroid hormone withdrawal, is either costly or cumbersome for patients.Aim: To compare the performance of basal T4 suppressed, with stimulated Tg measurement, in the follow up of patients treated for DTC.</...